Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 06 2021
Historique:
pubmed: 12 5 2021
medline: 29 6 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

To estimate the incidence of carbapenem-resistant

Identifiants

pubmed: 33972241
pii: AAC.02000-20
doi: 10.1128/AAC.02000-20
pmc: PMC8218680
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Carbapenems 0
beta-Lactamases EC 3.5.2.6
Meropenem FV9J3JU8B1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0200020

Références

PLoS One. 2017 Jun 21;12(6):e0179651
pubmed: 28636666
Infect Control Hosp Epidemiol. 2017 May;38(5):580-594
pubmed: 28294079
FEMS Microbiol Rev. 2017 May 1;41(3):252-275
pubmed: 28521338
Antimicrob Agents Chemother. 2015;59(6):3606-10
pubmed: 25801558
Clin Microbiol Infect. 2014 Sep;20(9):821-30
pubmed: 24930781
Euro Surveill. 2015;20(45):
pubmed: 26675038
Expert Rev Anti Infect Ther. 2017 Mar;15(3):277-297
pubmed: 27915487
Clin Microbiol Rev. 2020 Feb 26;33(2):
pubmed: 32102899
J Antimicrob Chemother. 2016 Aug;71(8):2131-8
pubmed: 27147304
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29038269
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S23-S33
pubmed: 30895212
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Nat Rev Microbiol. 2019 May;17(5):295-306
pubmed: 30837684
Clin Microbiol Rev. 2018 Feb 14;31(2):
pubmed: 29444952
Euro Surveill. 2017 May 11;22(19):
pubmed: 28537547
Front Microbiol. 2013 Mar 14;4:48
pubmed: 23504089
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205
pubmed: 30423057
Euro Surveill. 2013 Jul 11;18(28):
pubmed: 23870096
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S521-S528
pubmed: 31724045
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Int J Antimicrob Agents. 2018 Jun;51(6):848-853
pubmed: 29410368
Euro Surveill. 2010 Nov 18;15(46):
pubmed: 21144429
Euro Surveill. 2017 Feb 9;22(6):
pubmed: 28205502
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28652234
Antimicrob Agents Chemother. 2018 Nov 26;62(12):
pubmed: 30249690
Clin Infect Dis. 2018 Apr 3;66(8):1290-1297
pubmed: 29165604
J Antimicrob Chemother. 2017 May 1;72(5):1340-1349
pubmed: 28199647
J Glob Antimicrob Resist. 2013 Mar;1(1):7-16
pubmed: 27873609
J Antimicrob Chemother. 2012 Jul;67(7):1597-606
pubmed: 22499996
Sci Rep. 2018 May 31;8(1):8468
pubmed: 29855588
J Clin Microbiol. 2017 Jun;55(6):1638-1649
pubmed: 28298454
Antimicrob Agents Chemother. 2015 Oct 19;60(1):215-21
pubmed: 26482307
Antimicrob Agents Chemother. 2015 Nov;59(11):7080-3
pubmed: 26282410
MMWR Morb Mortal Wkly Rep. 2015 Dec 04;64(47):1315-6
pubmed: 26633574
Euro Surveill. 2019 Feb;24(9):
pubmed: 30862330
Int J Antimicrob Agents. 2018 Sep;52(3):372-384
pubmed: 29864500
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4490-500
pubmed: 27161636
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
Clin Microbiol Rev. 2017 Jan;30(1):1-22
pubmed: 27795305
Clin Microbiol Rev. 2019 Jan 30;32(2):
pubmed: 30700432
Lancet Infect Dis. 2019 Jun;19(6):601-610
pubmed: 31047852
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722889
J Antimicrob Chemother. 2017 Jan;72(1):166-171
pubmed: 27703058
Clin Microbiol Rev. 2015 Apr;28(2):337-418
pubmed: 25788514
Clin Microbiol Infect. 2019 Aug;25(8):943-950
pubmed: 31004767
Nat Rev Microbiol. 2020 May;18(5):286-298
pubmed: 32152509
J Antimicrob Chemother. 2019 Dec 1;74(12):3641-3643
pubmed: 31730158
J Antimicrob Chemother. 2016 May;71(5):1188-98
pubmed: 26869688
J Antimicrob Chemother. 2015 Jan;70(1):23-40
pubmed: 25261423
Euro Surveill. 2013 Aug 01;18(31):
pubmed: 23929228
Int J Antimicrob Agents. 2018 Aug;52(2):144-150
pubmed: 29510189
Clin Microbiol Infect. 2012 May;18(5):413-31
pubmed: 22507109
Antimicrob Agents Chemother. 2004 Aug;48(8):3203-6
pubmed: 15273152
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27799202

Auteurs

Krystyna M Kazmierczak (KM)

IHMA, Schaumburg, Illinois, USA.

James A Karlowsky (JA)

Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Boudewijn L M de Jonge (BLM)

Pfizer, Inc., Cambridge, Massachusetts, USA.

Gregory G Stone (GG)

Pfizer, Inc., Groton, Connecticut, USA.

Daniel F Sahm (DF)

IHMA, Schaumburg, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH